Inhaled Virus-Mimicking Particles Elicit Dose-Dependent Immune Response against SARS-CoV‑2 with Sex-Bias ACE2 Activity in Mice
Pei Zhang, Erik Niemelä, Panagiotis Filis, Pasi Sorvisto, Jani Virtanen, Hélder A. Santos · 2026
Read Inhaled Virus-Mimicking Particles Elicit Dose-Dependent Immune Response against SARS-CoV‑2 with Sex-Bias ACE2 Activity in Mice by Pei Zhang, Erik Niemelä, Panagiotis Filis, Pasi Sorvisto, Jani Virtanen, Hélder A. Santos (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13267171.txt.
Description
Pei Zhang and co-authors test an inhaled vaccine of virus-shaped particles against COVID in mice, in this 2026 study. The particles wear spikes from the Delta variant on their surface, arranged through a molecular Velcro pair. Breathing the vaccine in puts it where the virus lands, and the particles stayed in mouse lungs for at least a day. Female mice of a standard strain received the aspiration doses first.
Higher doses drew a strong, broad immune response across virus variants in a second, humanized mouse line. One twist: the virus's entry receptor behaved differently by sex, a bias worth tracking. Inhaled, variant-spanning vaccines could dodge needles and first-generation strain limits at once, if the mouse promise survives translation.
Catalog record
| CREATOR | Pei Zhang, Erik Niemelä, Panagiotis Filis, Pasi Sorvisto, Jani Virtanen, Hélder A. Santos |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |